January 10, 2020

Mayo Clinic, Helix to study the genetics of 100,000 patients

By Karl W Oestreich

Post-Bulletin
by Jeff Kiger

Mayo Clinic is partnering with a California-based firm to recruit 100,000 patients to participate in genetic testing to discover possible health problems and help develop a research database. Working with the genomics company Helix, Mayo Clinic is looking for patients to participate in a study called Tapestry that will initially test for 11 genes that signal three hereditary medical conditions, explained Dr. Konstantinos Lazaridis, the lead investigator of the study and associate director of the Mayo Clinic Center for Individualized Medicine. That means the Tapestry team, led by Dr. Keith Stewart, director of the Mayo Clinic Center for Individualized Medicine, will reach out to patients to see if they would like to participate in the study.

Rochester Post-Bulletin Logo

Reach: The Rochester Post-Bulletin is a daily newspaper that serves Rochester, Austin and its surrounding cities. The newspaper has a daily circulation of more than 30,000 and a weekend circulation of more than 36,000.  The Post-Bulletin online has more than 440,000 unique visitors to its website each month.

Additional coverage: Modern Healthcare, Becker’s Hospital Review, Austin Daily Herald, Med City News, Health Data Management, GenomeWeb, West Central Tribune

Context: Mayo Clinic is creating a library of genomic sequencing data on 100,000 consented Mayo Clinic participants to advance research and patient care.

“We believe that whole exome sequencing has the potential to reveal predispositions to health problems and enable earlier use of preventive measures throughout a person’s lifespan,” says Keith Stewart, M.B., Ch.B., Carlson and Nelson Endowed director, Mayo Clinic Center for Individualized Medicine. You can read more on Mayo Clinic News Network.

Contact: Colette Gallagher

Tags: Dr. Keith Stewart, Dr. Konstantinos Lazaridis, Mayo Clinic Center for Individualized Medicine, Post Bulletin, Uncategorized

Contact Us · Privacy Policy